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Abstract
There is broad interest in designing nanostructured materials that can interact with cells and 
regulate key downstream functions1–7. In particular, materials with nanoscale features may enable 
control over multivalent interactions, which involve the simultaneous binding of multiple ligands 
on one entity to multiple receptors on another and are ubiquitous throughout biology8–10. Cellular 
signal transduction of growth factor and morphogen cues that play critical roles in regulating cell 
function and fate often begins with such multivalent binding of ligands, either secreted or cell-
surface tethered, to target cell receptors, leading to receptor clustering11–18. Cellular mechanisms 
that orchestrate ligand-receptor oligomerisation are complex, however, and the capacity to control 
multivalent interactions and thereby modulate key signaling events within living systems is 
therefore currently very limited. Here we demonstrate the design of potent multivalent conjugates 
that can organise stem cell receptors into nanoscale clusters and control stem cell behaviour in 
vitro and in vivo. The ectodomain of ephrin-B2, normally an integral membrane protein ligand, 
was conjugated to a soluble biopolymer to yield multivalent nanoscale conjugates that potently 
induced signaling in neural stem cells and promoted their neuronal differentiation both in culture 
and within the brain. Super-resolution microscopy analysis yielded insights into the organisation 
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of receptor-ligand clusters at the nanoscale. We also found that synthetic multivalent conjugates of 
ephrin-B1 strongly enhanced human embryonic and induced pluripotent stem cell differentiation 
into functional dopaminergic neurons. Multivalent bioconjugates thus represent powerful tools and 
potential nanoscale therapeutics for controlling the behaviour of target stem cells in vitro and in 
vivo.
Adult neural stem cells (NSC) are an important class of therapeutically relevant cells, persist 
in specific regions of the mammalian brain, and have the capacity to generate new neurons 
and glia throughout life19. In addition, human pluripotent stem cells (hPSCs) – which 
include human embryonic stem cells (hESCs) and induced pluripotent stem cells (hiPSCs) – 
have the capacity to differentiate into all cells of the adult body and therefore offer broad 
potential for cell replacement therapy and modeling human disease. We recently found that 
ephrin-Eph signaling regulates both the neuronal differentiation of adult hippocampal 
NSCs19 and the differentiation of hESCs into dopaminergic neurons20, cells lost in 
Parkinson’s disease. The design of molecules that regulate ephrin-Eph signaling in NSCs 
and hPSCs could therefore advance both basic biology and therapeutic applications.
To create synthetic multivalent ligands with potentially high potencies, recombinantly 
produced ephrin-B2 extracellular domain was conjugated at a range of stoichiometries to 
high molecular weight hyaluronic acid (HA) – a well-characterised biopolymer present 
throughout the body and in particular within the brain – using EDC/Sulfo-NHS chemistry, 
as previously described21 (Fig. 1a,b). Valencies of the resulting ~100 nm polymeric 
conjugates22 – estimated using a bicinchoninic acid (BCA) assay and further quantified with 
size exclusion chromatography coupled with multi-angle light scattering (SEC-MALS) (Fig. 
1c) – ranged from 2 to 25 ephrin molecules per HA chain in this synthesis.
Based on the recently discovered role of ephrin-B2 signaling in regulating neuronal lineage 
commitment of adult NSCs19, we investigated the activity of the multivalent conjugates in 
NSC culture. At a given concentration of ephrin-B2 ectodomain molecules, increasing the 
valency of HA:Ephrin-B2 conjugates progressively elevated neuronal differentiation (Fig. 
1d,e). Strikingly, compared to antibody-clustered ligand, the 1:22, 1:12, and 1:8 valency 
conjugates induced similar levels of neuronal differentiation at 37-, 26-, and 9-fold lower 
protein concentrations, respectively. Thus, in contrast to the current, standard antibody-
clustered form, whose low potency necessitates high concentrations, the multivalent ligands 
are potent agonists, with potentially reduced cost. Next, the addition of monomeric ephrin-
B2 in tenfold molar excess to Fc-ephrin-B2 wells blocked differentiation, further 
establishing that ephrin clustering is required for activity. Finally, the results were further 
validated by quantifying mRNA levels of the neuronal marker Tubb3 (Fig. 1f).
We next compared the ability of natural and synthetic ligands to cluster Eph receptors. Since 
ephrin-B2 presented from astrocytes regulates the neuronal differentiation of adult NSCs19, 
we analyzed ephrin-Eph localisation on NSCs in contact with hippocampal astrocytes. 
Punctate staining of both ephrin-B2 and its receptor EphB4 was observed at cell-cell 
junctions (Fig. 2a), and co-localisation of the ligand and receptor was also observed at cell-
cell contacts in the subgranular zone (SGZ) of the adult hippocampus (Fig. 2b), where NSCs 
reside19.
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We then analyzed whether the multivalent conjugates could emulate this natural process of 
receptor-ligand assembly. Fluorescently-labeled ephrin-B2 conjugates were synthesised and 
incubated with NSCs, at 4 °C to block endocytosis. EphB4 localisation was diffuse across 
the cell membrane in the absence of ephrin-B2 or with low ratio conjugates, whereas EphB4 
puncta were observed in the presence of highly multivalent conjugates or antibody-clustered 
ligand (Fig. 2c). Additionally, while low ephrin-B2 valency conjugates yielded fewer and 
smaller EphB4 clusters than antibody-clustered ligand, high valency conjugates showed 
more (Fig. 2d), larger (Fig. 2e), and more intense (Fig. 2f) EphB4 clusters in close proximity 
(within the ~250 nm resolution limit of light microscopy) to fluorescently tagged ephrin-B2. 
Ligand multivalency therefore modulates both the number and the size of receptor clusters. 
In addition, we generated conjugates from ephrin-B2 protein recombinantly produced in 
mammalian cells and observed similar cell surface binding, indicating different protein 
expression systems result in similar downstream conjugate binding (Supplementary Fig. 1a).
Next, to explore the effect of ligand spacing on NSC differentiation and cell receptor 
clustering, monodisperse hyaluronic acid (HA) molecules of varying molecular weights 
were conjugated with recombinant ephrin-B2 extracellular domains tagged with fluorescent 
Alexa Fluor 647 molecules. Reactions were performed such that the polymers of varying 
molecular weights were linked to an equal number of fluorescently-tagged proteins, with the 
lower molecular weight conjugate containing an apparently saturated number of ephrin 
ligands (1:5 HA:Ephrin-B2 final molar ratio). The high molecular weight conjugates thus 
had greater inter-ligand spacing than lower molecular weight conjugates. After 6 days of 
culture, lower molecular weight conjugates induced significantly higher neuronal 
differentiation from NSCs, and higher molecular weight conjugates showed significantly 
less differentiation, compared to antibody-clustered Fc-ephrin-B2 (Fig. 2g). Inter-ligand 
spacing thus modulates conjugate activity.
Since standard fluorescence microscopy cannot accurately analyze the clustering properties 
of different molecular weight conjugates, we applied recently-developed super-resolution 
microscopy approaches to image receptor clusters on NSCs at 16 nm resolution. We 
generated a NSC line expressing an EphB4-Dendra223 fusion protein for photoactivatable 
localisation microscopy (PALM)24, which was combined with direct stochastic optical 
resolution microscopy (dSTORM)25 of Alexa Fluor 647-tagged HA:Ephrin-B2 conjugates 
(Fig. 2h). A single EphB4 and Ephrin-B2 signal were considered co-localised (and thus the 
molecules likely bound) when found to lie within the 16 nm resolution of the technique, 
corresponding to a single pixel in the images. We first analyzed receptor-ligand clusters for 
NSCs co-cultured with astrocytes and verified the existence of punctate staining at 
astrocyte-NSC junctions (Supplementary Fig. 2a), and co-localisation of ephrin-B2 with 
EphB4 was significantly more prevalent on NSCs when in contact with astrocytes 
(Supplementary Fig. 2b).
We next analyzed clusters generated by multivalent conjugates. In the absence of ligand, 
EphB4 was patchy but diffuse. However, after incubation of conjugates with cells for 4 
hours at 4 °C, the spacing between ephrin-B2 ligands that co-localised with EphB4 was 
significantly lower for the lower molecular weight HA conjugates (Fig. 2i). Furthermore, 
conjugates with closer ephrin-B2 inter-ligand spacing formed significantly more EphB4 
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clusters, which were also denser (i.e. higher number of co-localised EphB4-ephrin-B2 
signals per nm2), compared to conjugates with larger ephrin-B2 inter-ligand spacing (Fig. 
2j–l). Consequently, the shorter polymer conjugates resulted in more ligand-bound EphB4 
molecules per cell (Fig. 2m) and per individual cluster (Fig. 2n). Since the number of co-
localised EphB4-ephrin-B2 signals was larger than the valency of a single conjugate, each 
receptor-ligand cluster involved multiple bound conjugates, consistent with reports of lateral 
Eph receptor clustering26. Super-resolution imaging also confirmed that multivalent ligands 
produced in different expression systems yielded indistinguishable numbers, sizes, and 
densities of ligand-receptor clusters (Supplementary Fig. 3a–d). Modulating inter-ligand 
spacing can thus control the number of clusters per cell and number of receptors per cluster, 
potentially due to entropic effects associated with the conjugate’s polymer backbone27, and 
thereby control stem cell differentiation.
Ephrin-B2 induces neuronal differentiation by downstream activation of the transcriptional 
co-activator β-catenin19. Western blotting indicated that higher valency conjugate activated 
β-catenin significantly more than antibody-clustered Fc-ephrin or HA alone (Fig. 3a,b). 
Furthermore, a β-catenin responsive promoter-reporter construct showed a higher 
quantitative level of activation with increasing valency, which at a 1:31 valency was 
substantially greater than antibody-clustered Fc-ephrin-B2 (Fig. 3c). Finally, β-catenin 
drives neuronal differentiation via transcriptional activation of the proneural transcription 
factor NeuroD119, and multivalent ephrin-B2 conjugates with increasing valency again 
progressively induced higher levels of expression of this important target (Fig. 3d).
Multivalent conjugates may have strong utility not only in vitro but also in vivo. To 
investigate the latter, multivalent ephrin-B2 was administered into the hippocampal region 
of the adult rodent brain to analyze its ability to modulate endogenous stem cell function. 
Bromodeoxyuridine (BrdU) was administered to label dividing cells, followed by 
stereotactic injection of the ephrin-B2 conjugate or controls (Fig. 4a). After 5 days, the 
fractions of newly born cells (BrdU+) that had differentiated into neurons (DCX+) was 
quantified in tissue sections19. Antibody-clustered ligand showed a modest 20% increase 
over the uninjected or vehicle-injected HA control brains at the ephrin levels administered; 
however, the same number of ephrin-B2 domains incorporated into the highly multivalent 
conjugate yielded a substantial 60% increase in neurogenesis in the brain (Fig. 4b,c). These 
data demonstrate that nanoscale organisation in the presentation of this ligand greatly 
enhances its ability to elicit cellular responses both in vitro and in vivo.
We next assessed the generality of this approach with both hESCs and hiPSCs. Vazin et al. 
showed that unclustered ephrin-B1 – in combination with soluble stromal cell-derived 
factor-1 (SDF-1), pleiotrophin (PTN), and IGF-2, a blend known as SPIE – enhanced hESC 
differentiation into midbrain dopaminergic neurons20, which are being considered as cell 
replacement therapies for Parkinson’s disease28. By analogy with ephrin-B2, we synthesised 
multivalent ephrin-B1 conjugates. Using conjugates of varying valency, along with the other 
components of SPIE, hESCs were first differentiated within embryoid bodies and then 
toward dopaminergic neurons for 14–18 days (Fig. 5a). After 15 days, transcripts for the 
midbrain-specific marker En1 increased with higher valency (Fig. 5b), and QPCR showed 
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that both the pan-neuronal markerTubb3 and the dopaminergic marker TH progressively 
increased with conjugate valency (Fig. 5c).
Immunostaining was then conducted to quantify cell differentiation into a dopaminergic 
lineage. After 15–18 days of differentiation in ephrin post-embryoid body formation, hESC-
derived cultures exhibited substantially higher proportions of cells expressing pan-neuronal 
(Map2) and the dopaminergic neuron (TH) markers with increasing conjugate valency, 
compared to antibody-clustered ephrin-B1 (Fig. 5d–f). Similar results were achieved with 
hiPSCs (Supplementary Fig. 4a,b). Since contaminating cells within dopaminergic grafts 
have been associated with adverse events in clinical trials29, approaches to improve 
dopaminergic neuron purity are significant. Finally, to assess the functional properties of the 
differentiated dopaminergic neurons, levels of the neurotransmitter dopamine were 
measured, either in conditioned medium or upon addition of KCl to induce synaptic 
neurotransmitter release. Dopamine levels increased with increasing valency and were 
greater with highly multivalent conjugates than antibody-clustered groups (Fig. 5g), 
consistent with the observed higher dopaminergic differentiation levels observed with the 
conjugates.
As an initial assessment of how multivalent ephrin affects differentiating cultures, at various 
times over 14 days cells received a 24 hour pulse of bromodeoxyuridine (BrdU) to quantify 
DNA synthesis. Cells with multivalent ephrin-B1 remained mitotically active longer than 
with unclustered ephrin-B1 or no SPIE factors, indicating that enhanced proliferation of 
intermediate neuronal progenitors may increase the number of dopaminergic neurons in 
fully differentiated cultures (Fig. 5h). These results indicate that ephrin effects on 
dopaminergic differentiation are complex, and the multivalent conjugates will enable future 
mechanistic investigation of the role of this signaling system in dopaminergic neuron 
generation.
This study demonstrates that multivalency greatly enhances the bioactivity of ligands that 
regulate stem cell behaviour, and multivalent conjugates thus have utility for mechanistic 
investigation in both stem cell and developmental biology. Studying the mechanistic role of 
receptor complex assembly in cell-cell contact dependent Delta-Notch11, c-kit12, Fas 
ligand13, and Flt ligand14 signaling – as well as matrix-binding fibroblast growth factor 
(FGF)15, transforming growth factor-β (TGF-β)16, Hedgehogs (Hh)17, vascular endothelial 
growth factor (VEGF)18 signaling – and other signaling systems could greatly benefit from 
nanoscale synthetic ligands that potently activate receptors in a biomimetic fashion. For 
example, the effects of many receptor-ligand complex properties – including the number of 
receptor clusters per cell, cluster size, ligand scaffold, inter-receptor distance within an 
oligomer, and induced heteroligomerisation of different receptors into the same cluster – on 
biological activity can now be systematically varied and studied in vitro or in vivo. 
Furthermore, nanoscale multivalent conjugates could potentially activate these systems more 
potently, and thus less expensively. Finally, this platform has biotechnological and 
biomedical applications, including in cell culture systems, bioactive materials, and drug 
delivery technologies.
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METHODS
Recombinant protein production, purification, and bioconjugation
Murine ephrin-B2 ectodomain sequence (amino acids 31–227) was amplified from the 
plasmid pcDNA3.1-ephrin-B2-hFc (a kind gift from T. Miyamoto, Keio University), and 
human ephrin-B1 ectodomain sequence (amino acids 28–237) was amplified from 
pALTER-MAX (a kind gift from H. Sugimura, Hamamatsu University). A C-terminal 
hexahistidine tag and cysteine were added during PCR, followed by insertion into the 
bacterial expression plasmid pBAD. Protein was expressed in bacteria and purified as 
previously described21. Protein purity was assessed by confirmation of a single band 
following SDS-PAGE. Purified ephrin-B2 or ephrin-B1 was conjugated to 800 kDa 
hyaluronic acid (HA) (Genzyme) or to a range of monodisperse molecular weight HAs 
(Hyalose) through a two-step reaction using carbodiimide chemistry at the HA carboxylate 
group and a maleimide reaction at the protein C-terminal cysteine21. In the first step, 3,3′-N-
(ε-Maleimidocaproic acid) hydrazide (EMCH, Pierce, 1.2 mg/mL), N-
hydroxysulfosuccinimide (Sulfo-NHS, Pierce, 2.8 mg/mL), and 1-ethyl-3-(3-
dimethylaminopropyl) carbodiimide hydrochloride (EDC, Pierce, 10 mg/mL) were added to 
a 3 mg/mL solution of HA in 0.1 M 2-(N-morpholino)ethanesulfonic acid (MES) (Sigma) 
buffer pH 6.5 and allowed to react at 4 °C for 4 hours. The solution was then dialyzed into 
pH 7.0 PBS containing 10% glycerol and 2 mM EDTA. Recombinant ephrin-B2 or ephrin-
B1 was reduced using Tris(2-carboxyethyl)phosphine hydrochloride (TCEP) (Pierce) in 
200-fold molar excess and reacted at 4 °C for 5 minutes. Activated HA-EMCH was then 
added at desired molar ratios with reduced ephrin-B2 or ephrin-B1 and allowed to react at 4 
°C overnight. The ephrin-conjugated HA was dialyzed with 100 kDa MWCO tubing 
(Spectrum Labs) in pH 7.0 PBS containing 2 mM EDTA to remove unreacted ephrin. 
Purified ephrin and HA-conjugated ephrin protein concentrations were measured using a 
BCA assay, and valencies were verified using SEC-MALS as previously described21.
Antibody-clustered ephrin-B formation
To create clustered ephrin-B2 and ephrin-B1 complexes (Fc-ephrin-B), recombinant mouse 
ephrin-B/Fc chimera (R&D Systems) was incubated with goat anti-human IgG, Fc-fragment 
specific, (Jackson ImmunoResearch) antibody at a 1:9 ratio (w/w), which led to maximal 
activity of the resulting clusters (data not shown). After 90 min at 4 °C, complexes were 
used immediately.
Cell culture and differentiation
NSCs were cultured as previously described30. For differentiation studies, 8-well chamber 
slides were seeded with 2×104 cells per well in standard culture medium containing 0.1 
ng/mL FGF-2. For the subsequent 6 days, ephrin-B2 was added at the desired molar 
concentration, and daily 50% media changes were performed. EphB4 cluster properties were 
quantified using ImageJ.
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Immunostaining
Coronal brain sections (40 μm) were processed, stored, and stained as previously 
described31. Sections were then mounted on glass slides, and either stereological analysis 
(Stereo Investigator, MBF Biosciences) or confocal microscopy (LSM 710, Zeiss) was 
performed. In short, using an optical fractionator method, BrdU+ and DCX+ cells were 
counted in a Systematic Randomly Sampled (SRS) set of unbiased virtual volumes inside 
the subgranular zone and granular cell layer of both the left and right sides of the 
hippocampus. An estimate of the total number of DCX+/BrdU+ cells in the hippocampus 
was then generated.
Super-resolution microscopy
Cultures incubated with fluorescent conjugate were fixed and in some cases immunostained 
with Alexa 647 or Alexa 488 tagged antibodies, then incubated with 100 nm Tetraspeck 
fluorescent beads (Life Technologies) in PBS at a 1:2000 (v/v) dilution to act as reference 
points during imaging to later use for drift correction in image reconstruction. The sample 
coverslips were then placed in an Attofluor cell chamber (Life Technologies) and incubated 
in cold, freshly made pH 8.0 buffer containing 100 mM cysteamine (Sigma), 50 mM Tris, 
10 mM NaCl, 10% (wt/v) glucose, 560 μg/mL glucose oxidase (Sigma), and 34 μg/mL 
catalase (Sigma). Using a microscope (TE2000, Nikon) with adaptive optics for 3D 
localisation32, a piezoelectric stage, and highly inclined thin illumination capability33, 
photoactivatable localisation microscopy (PALM)24 was performed to detect EphB4-
Dendra223 simultaneously with direct stochastic optical reconstruction microscopy 
(dSTORM)25 to detect Alexa Fluor 647-tagged ephrin-B2 conjugates, as previously 
described24–25. Sub-diffraction limit images were then reconstructed using QuickPALM and 
quantified using ImageJ. To detect individual ephrin-B2 signals that co-localised with 
EphB4 signals, individual channel intensities were maximised, merged, then made into a 
binary image to display only co-localised pixels, indicating a proximity of signals within 16 
nm. EphB4 or ephrin-B2+ clusters were defined as any grouping of 10 or more positive 
pixels within a total diameter of 10 to 100 pixel widths.
Statistical analysis
Statistical significance of the results was determined using an ANOVA and multiple means 
comparison function (Tukey-Kramer method) in MATLAB with an alpha level of 0.05. All 
error bars are reported in s.d. from the mean, with n = 3 unless otherwise noted.
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Figure 1. 
Multivalent ephrin-B2 enhances neuronal differentiation of NSCs in vitro. (a) Chemical 
schematic of HA functionalisation and recombinant protein conjugation. (b) Schematic of 
protein (green) conjugation to 800 kDa linear HA (blue) and subsequent clustering of 
receptors (red) upon introduction to cells, inducing neuronal differentiation. The molecular 
structure represents an HA monomer subunit, of which there are approximately 2,111 (n) in 
800 kDa HA. The ratio of a:b represents the valency of HA molecules to covalently-bound 
protein subunits. (c) Comparative BCA vs. SEC-MALS analysis for a range of ephrin-B2 
bioconjugate valencies. (d) Representative images of cultured NSCs differentiated for 6 
days in media alone (naïve) or in the presence of unclustered ephrin-B2, antibody clustered 
Fc-ephrin-B2, or multivalent 1:22 HA:Ephrin-B2, then immunostained for the neuronal 
marker βIII-Tubulin (green) and total nuclei (blue). Scale bars, 100 μm. (e) Quantification of 
the total fraction of neurons after 6 days of NSC differentiation in the presence of ephrin-B2 
conjugates (dashed lines) or controls (solid lines), as assessed by immunostaining. * P < 
0.05 compared to Fc-ephrin-B2 at corresponding ephrin-B2 concentrations. (f) qPCR for the 
neuronal transcript Tubb3 after 6-day differentiation. * P = 0.0159, ** P = 0.0037. All error 
bars represent s.d. from the mean.
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Figure 2. 
Multivalent ephrin-B2 enhances receptor clustering. (a) Representative image of EphB4 
(red) and ephrin-B2 (white) clustering (white arrow heads) on the surface of NSCs (stained 
with the neural stem cell marker nestin, pseudo-coloured green, and outlined with white 
dashed lines) and hippocampal astrocytes (edges outlined with grey dashed lines), 
respectively, in co-culture. All cell nuclei are shown in blue. Scale bars, 10 μm. (b) EphB4 
(green) receptor clustering (white arrow heads) on the surface of multiple cells in the 
hippocampal subgranular zone (SGZ) in contact with ephrin-B2+ astrocytes (red). All cell 
nuclei are shown in blue. Scale bars, 10 μm. (c) Representative images of NSCs incubated 
with fluorescently labeled ephrin-B2 bioconjugates (white) for 4 hours at 4 °C and 
immunostained for their cognate receptor EphB4 (red), the neural stem cell marker nestin 
(green), and total nuclei (blue). White arrow heads indicate ephrin-B2/EphB4 co-
localization. Scale bars, 10 μm. (d) Quantification of total number of EphB4 puncta per cell 
after incubation with ephrin-B2, either antibody-clustered or a new preparation of conjugate. 
* P = 0.024 by ANOVA, n ≥ 10. (e) Normalised area per EphB4 punctum after incubation 
with ephrin-B2. * P = 5.33×10−9 by ANOVA, n ≥ 62. (f) Normalised mean EphB4 signal 
intensity per punctum after incubation with ephrin-B2. * P = 0.001 by ANOVA, n ≥ 62. (g) 
Immunostaining quantification of the total fraction of neurons after 6 days of NSC 
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differentiation in the presence of Alexa Fluor 647 tagged ephrin-B2 conjugates of varying 
HA backbone molecular weight and antibody-clustered Fc-ephrin-B2 control, all at 200 nM 
protein concentration. * P < 0.02 compared to Fc-ephrin-B2. (h) Representative 
reconstructed super-resolution images of EphB4-Dendra2 (red) NSCs incubated with 
fluorescently labeled ephrin-B2 bioconjugates (blue) for 4 hours at 4 °C and then 
immunostained for the neural stem cell marker nestin (green). Magnified images of 
representative EphB4/ephrin-B2 clusters are shown below whole cell images, with co-
localised pixels indicated in white. Large scale bars, 1000 nm; small scale bars, 100 nm. (i) 
Quantification of average inter-ligand spacing between individual ephrin-B2 signals that co-
localised with EphB4, with a constant value of 16 nm per pixel. * P = 1.80×10−6. ** P = 
0.0006. *** P = 1.22×10−6. (j) Quantification of total number of EphB4 clusters per cell 
after incubation with fluorescent ephrin-B2. * P = 0.0009. (k) Normalised area per EphB4 
cluster after incubation with fluorescent ephrin-B2. * P = 5.33×10−9. (l) Normalised number 
of co-localised EphB4-ephrin-B2 signals per nm2 after incubation with ephrin-B2. * P = 
0.0015. (m) Total number of co-localised EphB4-ephrin-B2 signals per cell after incubation 
with fluorescent ephrin-B2. * P = 0.0064. (n) Total number of EphB4 signals per cluster 
after incubation with fluorescent ephrin-B2. * P < 0.05. All error bars represent s.d. from the 
mean.
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Figure 3. 
Multivalent ephrin-B2 enhances downstream signaling. (a) Representative Western blot for 
active β-catenin and GAPDH, as a loading control, in NSC lysate after 24 hour incubation 
with ephrin-B2 bioconjugates. (b) Average levels of β-catenin activation normalised to 
GAPDH in n=3 blots. * P = 0.0217. (c) Quantification of β-catenin activation in NSCs after 
24-hour incubation with fluorescently labeled ephrin-B2 bioconjugates at 37 °C, as assessed 
by upregulation of the transgenic luciferase reporter for β-catenin activity. * P = 0.0267. (d) 
qPCR for the intermediate transcriptional target of neurogenesis NeuroD1 after 6 day 
differentiation. The RA/FBS group is described in detail in the Methods section. * P = 
0.0192. All error bars represent s.d. from the mean.
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Figure 4. 
Multivalent ephrin-B2 enhances in vivo neurogenesis. (a) Schematic of experimental 
timecourse. (b) Representative image of adult rat hippocampal sections 5 days after 
stereotactic injections, immunostained for BrdU (red) to label dividing cells, DCX (green) to 
label immature neurons, and DAPI to stain nuclei (blue). Scale bars, 100 μm. (c) 
Quantification of the overall fraction of newborn hippocampal cells that underwent neuronal 
differentiation using stereological estimation. * P = 0.0136, ** P = 0.0015. All error bars 
represent s.d. from the mean.
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Figure 5. 
Multivalent ephrin-B1 enhances neuronal and midbrain fates in differentiating hESCs. (a) 
Schematic of experimental timecourse. (b) RT-PCR analysis of midbrain-specific marker 
En1 expression vs. control G3PDH, from HSF6 hESCs differentiated for 15 days post-
embryoid body formation with ephrin-B1 conjugates or controls. (c) qPCR for the pan-
neuronal markerTubb3 and the dopaminergic marker TH after 15-day differentiation of H1 
hESCs with ephrin-B1 conjugates or controls. * P < 0.05 compared to SPIE for 
corresponding neuronal marker. (d) Representative images of cultured H1 hESCs 
differentiated for 18 days post-embryoid body formation with the SPI factors, heparin, and 
either Fc-ephrin-B1 or multivalent 1:36 HA:Ephrin-B1. Immunostaining for total neurons 
(green), dopaminergic neurons (red), and total nuclei (blue). Scale bars, 100 μm. (e) 
Quantification of the fraction of total neurons after differentiation of H1 hESCs in the 
presence of ephrin-B1 conjugates or controls, as assessed by immunostaining. * P = 0.0181, 
** P = 0.0029. (f) Quantification of the fraction of dopaminergic neurons after 
differentiation of H1 hESCs in the presence of ephrin-B1 conjugates or controls, as assessed 
by immunostaining. * P = 0.0328, ** P = 0.0004. (g) Quantification of the fraction of 
mitotic cells on various days over the 14 day course of HSF6 hESC differentiation in the 
presence of ephrin-B1 conjugates (dashed lines) or controls (solid lines). (h) Quantification 
of total dopamine levels in cultures of H1 hESCs differentiated for 4 weeks in the presence 
of ephrin-B1 conjugates or controls, as assessed by HPLC with electrochemical detection. 
All error bars represent s.d. from the mean.
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